The company that walked into an American pharmacy, asked the rude question - "how much, really?" - and built a business on the answer.
Above: the GoodRx wordmark. Yes, the "Rx" is doing a lot of work. So is the company.
A patient stands at a pharmacy counter, phone in hand. The pharmacist names a number. The patient names a smaller one, reading it off a coupon. The smaller number wins. This small, slightly awkward standoff happens millions of times a day - and it is, in essence, the entire GoodRx product.
GoodRx is a digital healthcare platform built on a deceptively simple premise: that you should be allowed to know what your medicine costs before you pay for it. Roughly 30 million Americans have used it. It aggregates real-time prices and discounts from pharmacies across the country, hands consumers free coupons, and - increasingly - wraps telehealth visits, manufacturer savings, and employer programs around that core search box.
Fifteen years in, it is profitable, public, and still arguing the same point it opened with.
"Type in a pill. Get a price. The radical part is that this was ever radical."
Here is the inconvenient truth GoodRx was built around: in the United States, the same drug can cost wildly different amounts depending on which pharmacy you walk into, what your insurance is, and whether anyone bothered to tell you. Cash prices swing. Coupons sometimes beat insurance copays. The numbers are real, but nobody publishes them in one place.
The story the founders tell is almost too tidy. In 2010, co-founder Doug Hirsch went to fill a prescription, balked at the price, and started shopping around - only to find there was no single place to compare. Two pharmacies on the same street, two very different numbers, and no map. That gap between what a drug costs and what you're told it costs is the tension the whole company runs on.
"The prices were always there. They were just never in the same room as the patient."
GoodRx was founded in 2011 in Santa Monica by Doug Hirsch, Scott Marlette, and Trevor Bezdek. Two of them - Hirsch and Marlette - came out of Facebook's early product ranks; Hirsch had also been among Yahoo!'s first thirty employees. They were, in other words, people who understood that the answer to "how do I find the cheapest thing" is usually a well-built index, not a phone call.
The bet was unfashionable for healthcare: don't charge the patient. Make the tool free, aggregate the messy pricing data nobody else had organized, and figure out the money later. It turned out "later" meant fees from the pharmacy-benefit middlemen who suddenly had a reason to route discounted volume through GoodRx.
Ex-Yahoo! (first ~30 employees), ex-Facebook VP of Product. The one who actually got sticker shock at the counter.
The technologist of the trio; served as co-CEO as GoodRx scaled from coupon site to public company.
Also out of early Facebook. Helped turn a pile of pricing data into something people could search.
Three founders, two of them Facebook alumni, all of them convinced a pharmacy receipt should not be a surprise party.
At its heart, GoodRx is free. You search a medication, see prices across nearby pharmacies, and pull up a coupon that frequently lands below the cash price - and sometimes below your own insurance copay. That is the part most people meet first. Around it, the company has built a fuller stack:
Real-time price comparison across U.S. pharmacies, with free coupons. Always the front door.
Launched May 2026 at $14.99/mo: low-cost generics, $19 telehealth visits, plus dental, vision, lab and imaging savings.
Online doctor visits and prescribing for common conditions, stitched to the pharmacy savings.
Manufacturer affordability programs - including GLP-1s like Wegovy and Zepbound - routed to self-pay patients.
Launched Feb 2026: employer-funded subsidies that cut out-of-pocket costs on high-impact brand drugs.
A consumer library of medication and health information, written by clinicians.
"Free for the patient. Paid for by everyone who suddenly wanted the patient's business."
Skeptics are right to ask whether a free coupon site can be a real business. The financials suggest it can. GoodRx posted FY2025 revenue of $796.9M with an adjusted EBITDA margin near 34% - healthy by any software standard, let alone healthcare. Its pharma-manufacturer business has become a genuine growth engine, with Pharma Direct revenue up 41% to $151M and Q1 2026 revenue of $194.0M.
Estimated savings of $70B+ is the kind of number that sounds made up until you remember how many people fill a prescription every single day.
The partnerships tell the same story from another angle. Pharmacies and PBMs honor GoodRx pricing at the counter. Drugmakers plug brand affordability programs - the GLP-1 weight-loss drugs especially - into Pharma Direct. Employers now buy subsidies through Employer Direct. Each one is a different party deciding that a patient who can find a price is a patient worth reaching.
"$70 billion in savings, one slightly awkward counter conversation at a time."
GoodRx states its mission plainly: help Americans get the healthcare they need at a price they can afford, by bringing transparency to drug pricing. It is the rare mission statement that doubles as the product spec. The company isn't promising to fix the U.S. healthcare system - a sensible thing to avoid promising - but it is insisting that the first step is letting people see the prices.
The competitive set has noticed. SingleCare, RxSaver, Blink Health, Optum Perks, Amazon Pharmacy, and Mark Cuban's Cost Plus Drugs are all circling the same idea from different directions. Transparency, it turns out, is contagious.
The 2026 moves - Companion, Employer Direct, deeper GLP-1 access - point at where GoodRx wants to go: from a tool you reach for at the counter to a standing relationship with your everyday healthcare costs. Whether a $14.99 subscription can sit comfortably next to a free coupon is the open question, and a strategy pivot is never as clean in practice as it looks in a press release.
But the core thesis hasn't moved an inch since 2011. Prices should be visible. People should be able to choose. Everything else is distribution.
Back at that pharmacy counter: the patient reads the smaller number, the pharmacist rings it up, and the standoff resolves the way it now resolves millions of times a day. The medicine costs what GoodRx says it costs. That used to be a surprise. Now it's just Tuesday.